Tetsuo Ito
YOU?
Author Swipe
View article: Unclassifiable Congenital Biliary Dilatation With a Meandering Main Pancreatic Duct and Suspected Pancreaticobiliary Maljunction
Unclassifiable Congenital Biliary Dilatation With a Meandering Main Pancreatic Duct and Suspected Pancreaticobiliary Maljunction Open
Congenital biliary dilatation (CBD) is a congenital disorder in which the bile ducts are locally or diffusely dilated and is specifically defined as a disorder associated with pancreaticobiliary maljunction (PBM). PBM is a congenital anoma…
View article: A Rare Case of Gastropleural Fistula During Chemotherapy for Metastatic Colorectal Cancer
A Rare Case of Gastropleural Fistula During Chemotherapy for Metastatic Colorectal Cancer Open
Gastropleural fistula (GPF) is a rare and life-threatening condition, often associated with peptic ulcer disease, trauma, abscess, malignancies, prior surgeries, or chemoradiation therapy. Its rarity, diverse clinical presentations, and th…
View article: Supplementary Figure S1 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Supplementary Figure S1 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Supplementary Figure S1 from Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
View article: Supplementary Figure S2 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S2 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S2 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure Legend from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure Legend from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure Legend from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure S2 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S2 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S2 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Data from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
Data from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Open
Purpose: Our aim was to investigate whether and at what stage hypermethylation of the tachykinin-1 (TAC1) gene is associated with human esophageal neoplastic transformation.Experimental Design:TAC1 promoter hypermethylation was examined by…
View article: Supplementary Figure S3 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S3 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S3 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Tables S1 & S2 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Supplementary Tables S1 & S2 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Supplementary Tables S1 & S2 from Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
View article: Data from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
Data from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Open
Purpose: Our aim was to investigate whether and at what stage hypermethylation of the tachykinin-1 (TAC1) gene is associated with human esophageal neoplastic transformation.Experimental Design:TAC1 promoter hypermethylation was examined by…
View article: Supplementary Figure Legend from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure Legend from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure Legend from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure S1 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S1 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S1 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure S3 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S3 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S3 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure S1 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Supplementary Figure S1 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Supplementary Figure S1 from Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
View article: Data from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Data from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
In this study, we investigated the clinicopathologic significance of the low-affinity p75 neurotrophin receptor (p75NTR; which is expressed in the stem/progenitor cell fraction of normal esophageal epithelial cells) in 187 resected esophag…
View article: Data from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Data from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Purpose: We previously reported that the expression of Aurora-A was frequently up-regulated in human esophageal squamous cell carcinoma (ESCC) tissues as well as cell lines and the up-regulation contributed to a poor prognosis. In this stu…
View article: Data from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Data from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Purpose: We previously reported that the expression of Aurora-A was frequently up-regulated in human esophageal squamous cell carcinoma (ESCC) tissues as well as cell lines and the up-regulation contributed to a poor prognosis. In this stu…
View article: Supplementary Tables S1 & S2 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Supplementary Tables S1 & S2 from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Supplementary Tables S1 & S2 from Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
View article: Data from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Data from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Purpose:Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer. Our aim was to determine …
View article: Supplementary Figure S1 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Supplementary Figure S1 from The Suppression of <i>Aurora-A/STK15/BTAK</i> Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma Open
Supplementary Figure S1 from The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
View article: Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
Supplementary Figure 3 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
View article: Data from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Data from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
In this study, we investigated the clinicopathologic significance of the low-affinity p75 neurotrophin receptor (p75NTR; which is expressed in the stem/progenitor cell fraction of normal esophageal epithelial cells) in 187 resected esophag…
View article: Data from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression
Data from <i>Reprimo</i> Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Open
Purpose:Reprimo, a candidate tumor-suppressor gene, regulates p53-mediated cell cycle arrest at G2 phase, and tumor-suppressor gene methylation is involved in the pathogenesis and progression of esophageal cancer. Our aim was to determine …
View article: Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
View article: Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Open
Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
View article: Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Open
Supplementary Table S1 from Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer
View article: Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma Open
Supplementary Figures 1,2,4,5,6 from The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma